Tailoring the Future: Emerging Data Guiding an Individualized Treatment Approach for Central Precocious Puberty : Episode 5

Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty

September 4, 2024

By Karen O. Klein, MD
Jill Samis, MD

Opinion

Video

The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.

EP: 1.Overview Of Central Precocious Puberty

EP: 2.Diagnosis of Central Precocious Puberty and its Psychosocial Impact

EP: 3.Early Diagnosis and Treatment for Central Precocious Puberty

EP: 4.Treatment Options for Central Precocious Puberty

Now Viewing

EP: 5.Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty

EP: 6.Individualized Management of Central Precocious Puberty

EP: 7.Central Precocious Puberty Treatment Starts, Discontinuations and Misconceptions

EP: 8.Central Precocious Puberty in Male Patients

EP: 9.Recommendations and Outlook for Central Precocious Puberty

Video content above is prompted by the following:

What are long-term efficacy and safety data associated with gonadotropin releasing hormone analogue (GnRHa) treatment?

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!